加味寿胎丸治疗多囊卵巢综合征合并复发性流产临床效果及对血栓前状态的影响

王世帅; 叶利群; 单丽华; 吴淋淋

doi:10.16766/j.cnki.issn.1674-4152.003118

加味寿胎丸治疗多囊卵巢综合征合并复发性流产临床效果及对血栓前状态的影响

doi: 10.16766/j.cnki.issn.1674-4152.003118

1.
宁波市中医院妇科，浙江宁波 315010
2.
金华市人民医院妇科，浙江金华 321000

基金项目:

浙江省卫生健康科技计划项目 2021KY1184

宁波市科技计划项目 2019A610358

详细信息

通讯作者:
叶利群，E-mail：yeliqunnb@sina.com

中图分类号: R711.75 R714.21 R242
计量
- 文章访问数: 182
- HTML全文浏览量: 52
- PDF下载量: 5
- 被引次数: 0
出版历程
- 收稿日期: 2023-03-29
- 网络出版日期: 2023-09-13

Clinical efficacy of Jiawei Shoutai Pills in the treatment of polycystic ovary syndrome with recurrent miscarriage and its impact on pre thrombotic state

1.
Ningbo Traditional Chinese Medicine Hospital Gynecology, Ningbo, Zhejiang 315010, China

摘要

摘要: 目的分析加味寿胎丸治疗多囊卵巢综合征合并复发性流产患者的临床疗效，及对患者血栓前状态的影响，为临床治疗提供依据。方法选取2019年7月—2021年6月宁波市中医院收治的150例多囊卵巢综合征合并复发性流产患者组作为研究对象，采用随机数表法分为A组(低分子肝素钙注射液治疗)、B组(加味寿胎丸治疗)及C组(加味寿胎丸联合低分子肝素钙注射液治疗)，每组50例。比较各组患者治疗前后中医症候评分、内分泌指标、凝血-纤溶指标、抗心磷脂抗体及子宫动脉血流动力学状态变化。结果治疗后，C组患者中医症候评分为4.00(1.46，8.00)分，明显低于A组的10.00(3.75，11.25)分及B组的11.21(4.60，12.18)分，P < 0.05；C组血清人绒毛膜促性腺激素(β-HCG)、孕激素(P)、雌二醇(E₂)均高于B组和A组(均P < 0.05)；C组活化部分凝血活酶时间(APTT)及抗凝血酶Ⅲ(ATⅢ)均高于B组及A组，纤维蛋白原(FIB)、D-二聚体(DD)均低于B组及A组(均P < 0.05)；C组患者抗心磷脂抗体阳性率为10.0%(5/50)，低于A组的28.0%(14/50)及B组的28.0%(14/50)，P < 0.05。结论加味寿胎丸联合低分子肝素钙注射液治疗多囊卵巢综合征合并复发性流产能有效改善患者血浆黏度、凝血、纤溶系统及子宫动脉血流动力学状态，值得临床应用。
- 多囊卵巢综合征 /
- 复发性流产 /
- 血栓前状态 /
- 加味寿胎丸 /
- 凝血-纤溶
Abstract: Objective Analyze the clinical efficacy of Jiawei Shoutai Pills in treating patients with polycystic ovary syndrome combined with recurrent miscarriage, and its impact on the patient's pre thrombotic state, providing a basis for clinical treatment. Methods A total of 150 patients with polycystic ovary syndrome and recurrent miscarriage admitted to Ningbo Traditional Chinese Medicine Hospital from July 2019 to June 2021 were selected as the study subjects, They were randomly divided into A team (low molecular weight heparin calcium injection treatment), B team (modified Jiawei Shoutai Pills treatment) and C team (modified Jiawei Shoutai Pills combined with low molecular weight heparin calcium injection treatment), with 50 patients in each team.Compare the TCM syndrome score and endocrine index, coagulation- fibrinolysis index, anticardiolipin antibody. Results After treatment, the C team score of patients was 4.00 (1.46, 8.00) points, lower than the 10.00 (3.75, 11.25) points in the A team and the 11.21 (4.60, 12.18) points in the B team, P < 0.05; C team serum β-human chorionic gonadotropin (β-HCG), progesteroneon (P), estradiol (E₂) were all higher than the B team and A team, P < 0.05; The activated partial thromboplastin time (APTT) and AntithrombinⅢ (ATⅢ) levels in the C team were higher than the traditional Chinese medicine and A team, while fibrinogen (FIB) and d-dimmer (DD) levels were lower than the B team and A team, with P < 0.05; The positive rate of anticardiolipin antibodies in the C team was 10.0% (5/50), which was lower than the LMWH and the Chinese medicine team, all were 28.0% (14/50), P < 0.05. Conclusion Jiawei Shoutai Pills combined with low-molecular-weight heparin calcium injection can effectively improve plasma viscosity, coagulation, fibrinolysis system and uterine artery hemodynamics in patients with polycystic ovary syndrome complicated with recurrent abortion, worthy of clinical application.
- Polycystic ovary syndrome /
- Recurrent abortion /
- Prethrombotic state /
- Jiawei Shoutai Pills /
- Coagulation fibrinolysis

HTML全文

表 1 3组多囊卵巢综合征合并复发性流产患者中医症候评分比较[M(P₂₅, P₇₅)，分]

Table 1. Comparison of traditional Chinese medicine syndrome scores in 3 groups of patients with polycystic ovary syndrome complicated with recurrent abortion[M(P₂₅, P₇₅), points]

组别	例数	治疗前	治疗后
A组	50	16.50(7.25，21.75)	10.00(3.75，11.25)^a
B组	50	17.00(7.00，21.00)	11.21(4.60，12.18)^a
C组	50	18.00(9.00，27.00)	4.00(1.46，8.00)^abc
H值		0.769	20.195
P值		0.361	< 0.001
注：与同组治疗前比较，^aP < 0.05；与治疗后A组比较，^bP < 0.05；与治疗后B组比较，^cP < 0.05。

下载: 导出CSV

表 2 3组多囊卵巢综合征合并复发性流产患者内分泌指标比较[M(P₂₅, P₇₅)]

Table 2. Comparison of endocrine indexes in 3 groups of patients with polycystic ovary syndrome complicated with recurrent abortion[M(P₂₅, P₇₅)]

组别	例数	血清β-HCG(mIU/mL)		P(ng/mL)		E₂(pg/mL)
组别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
A组	50	27 343.00(16 973.25，110 919.75)	129 744.00(66 712.75，200 138.25)^a	21.68(10.60，31.80)	26.02(10.26，30.78)^a	562.00(360.75，2 882.25)	1 220.00(755.50，3 766.50)^a
B组	50	26 448.50(10 351.75，121 055.25)	115 064.50(66 700.00，200 100.00)^a	19.18(10.35，31.05)	21.84(10.51，31.52)^a	533.00(360.75，2 882.25)	1 843.50(867.00，3 201.00)^a
C组	50	24 417.00(11 450.00，124 350.00)	186 767.50(67 200.00，201 600.00)^abc	19.51(10.12，30.35)	33.10(10.67，32.01)^abc	563.50(312.25，2 136.75)	2 002.00(853.75，3 761.25)^abc
H值		0.166	11.871	0.360	7.628	0.162	8.241
P值		0.753	< 0.001	0.645	< 0.001	0.875	< 0.001
注：与同组治疗前比较，^aP < 0.05；与治疗后A组比较，^bP < 0.05；与治疗后B组比较，^cP < 0.05。

下载: 导出CSV

表 3 3组多囊卵巢综合征合并复发性流产患者凝血-纤溶指标比较

Table 3. Comparison of coagulation and fibrinolysis indexes in 3 groups of patients with polycystic ovary syndrome complicated with recurrent abortion

组别	例数	APTT(x±s，s)		FIB[M(P₂₅, P₇₅)，mg/dL]		DD[M(P₂₅, P₇₅)，ng/mL]		ATⅢ(x±s，%)
组别	例数	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后	治疗前	治疗后
A组	50	29.80±3.24	30.74±1.75	403.50(120.00, 360.00)	386.50(113.5, 340.5)^b	99.00(78.00, 374.00)	90.00(60.75, 272.25)^b	82.71±3.49	85.40±3.45^b
B组	50	29.74±3.17	30.82±1.80	403.50(120.00, 360.00)	384.50(111.10, 332.80)^b	100.00(73.75, 383.47)	90.00(51.00, 273.00)^b	82.63±3.30	85.65±3.11^b
C组	50	29.73±3.25	31.80±2.68^bcd	405.50(129.50, 358.50)	365.00(86.50, 309.50)^bcd	99.50(52.25, 327.75)	86.00(36.00, 168.00)^bcd	82.75±3.39	87.16±3.52^bcd
统计量		0.007^a	3.875^a	0.081^e	3.901^e	0.080^e	3.346^e	0.016^a	4.004^a
P值		0.993	0.023	0.922	0.013	0.942	0.041	0.984	0.020
注：^a为F值，^e为H值；与同组治疗前比较，^bP < 0.05；与治疗后A组比较，^cP < 0.05；与治疗后B组比较，^dP < 0.05。

下载: 导出CSV

表 4 3组多囊卵巢综合征合并复发性流产患者抗心磷脂抗体比较[例(%)]

Table 4. Comparison of anti-cardiolipin antibodies in 3 groups of patients with polycystic ovary syndrome complicated with recurrent abortion[cases(%)]

组别	例数	治疗前	治疗后
A组	50	30(60.0)	14(28.0)^a
B组	50	31(62.0)	14(28.0)^a
C组	50	30(60.0)	5(10.0)^abc
χ²值		0.056	6.294
P值		0.972	0.043
注：与同组治疗前比较，^aP < 0.05；与治疗后A组比较，^bP < 0.05；与治疗后B组比较，^cP < 0.05。

下载: 导出CSV

参考文献(22)

[1]	陈锦明, 张芬, 邓姣, 等. 中医体质类型与多囊卵巢综合征相关性的meta分析[J]. 中华全科医学, 2022, 20(4): 691-695. doi: 10.16766/j.cnki.issn.1674-4152.002432 CHEN J M, ZHANG F, DENG J, et al. Correlation between TCM constitution and polycystic ovary syndrome: a meta-analysis[J]. Chinese Journal of General Practice, 2022, 20(4): 691-695. doi: 10.16766/j.cnki.issn.1674-4152.002432
[2]	刘丹, 伍曼玉, 黄新颜, 等. 复发性流产史患者妊娠早期检测血栓前状态指标的意义[J]. 中国医刊, 2022, 57(9): 1020-1023. doi: 10.3969/j.issn.1008-1070.2022.09.027 LIU D, WU M Y, HUANG X Y, et al. The significance of detecting pre thrombotic state indicators in early pregnancy of patients with a history of recurrent miscarriage[J]. Chinese Journal of Medicine, 2022, 57(9): 1020-1023. doi: 10.3969/j.issn.1008-1070.2022.09.027
[3]	ZEHRAVI M, MAQBOOL M, ARA I. Polycystic ovary syndrome and infertility: an update[J]. Int J Adolesc Med Health, 2021, 34(2): 1-9.
[4]	李晖, 褚玉霞, 孙红. 加味褚氏安胎方联合常规治疗对肾虚血瘀型血栓前状态致复发性流产患者的临床疗效[J]. 中成药, 2022, 44(10): 3170-3174. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA202210015.htm LI H, CHU Y X, SUN H. Clinical effects of Supplemented CHU's Antai Decoction combined with conventional treatment on patients with recurrent miscarriage in prethrombotic state due to Kidney Deficiency and Blood Stasis[J]. Chinese Traditional Patent Medicine, 2022, 44(10): 3170-3174. https://www.cnki.com.cn/Article/CJFDTOTAL-ZCYA202210015.htm
[5]	刘蓉, 汪维, 胡繁. 补肾舒肝法联合低分子肝素钠治疗血栓前状态引起的复发性流产效果[J]. 中国计划生育学杂志, 2022, 30(4): 865-868. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202204030.htm LIU R, WANG W, HU F. Efficacy of kidney-tonifying and liver-relieving method combined with low molecular weight heparin for treating women with recurrent miscarriage caused by prethrombotic state[J]. Chinese Journal of Family Planning, 2022, 30(4): 865-868. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202204030.htm
[6]	莫琳玲, 彭丹, 宋金玲, 等. 低分子肝素与小剂量阿司匹林治疗复发性流产血栓前状态的效果及其免疫调节作用研究[J]. 中国性科学, 2022, 31(9): 81-85. https://www.cnki.com.cn/Article/CJFDTOTAL-XKXZ202209021.htm MO L L, PENG D, SONG J L, et al. The effect of low molecular weight heparin and low dose aspirin on prethrombotic state in recurrent spontaneous abortion and its function of immune regulation[J]. Chinese Journal of Human Sexuality, 2022, 31(9): 81-85. https://www.cnki.com.cn/Article/CJFDTOTAL-XKXZ202209021.htm
[7]	DONG P P, LING L, HU L. Systematic review and meta-analysis of traditional Chinese medicine compound in treating infertility caused by endometriosis[J]. Ann Palliat Med, 2021, 10(12): 12631-12642. doi: 10.21037/apm-21-3425
[8]	崔琳琳, 陈子江. 多囊卵巢综合征诊断标准和诊疗指南介绍[J]. 国际生殖健康/计划生育杂志, 2011, 30(5): 405-408. doi: 10.3969/j.issn.1674-1889.2011.05.018 CUI L L, CHEN Z J. Diagnosis Criteria and Guidelines for the Diagnosis and Treatment of PCOS[J]. International Journal of Reproductive Health/Family Planning, 2011, 30(5): 405-408. doi: 10.3969/j.issn.1674-1889.2011.05.018
[9]	中华医学会妇产科学分会产科学组. 复发性流产诊治的专家共识[J]. 中华妇产科杂志, 2016, 51(1): 3-9. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201811011.htm Obstetrics Group, Branch of Obstetrics and Gynecology, Chinese Medical Association. Expert consensus on diagnosis and treatment of recurrent abortio[J]. Chinese Journal of Obstetrics and Gynecology, 2016, 51(1): 3-9. https://www.cnki.com.cn/Article/CJFDTOTAL-SFCZ201811011.htm
[10]	梁茂新, 高天舒. 《中药新药临床研究指导原则》脏腑诸证考察与分析[J]. 中国中医基础医学杂志, 2008, 14(5): 330-331, 342. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC200805004.htm LIANG M X, GAO T S. Guiding Principles for Clinical Research of New Traditional Chinese Medicine "Investigation and Analysis of Organ Syndrome[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2008, 14(5): 330-331, 342. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYJC200805004.htm
[11]	曹天澈, 陆启滨, 许家莹. 从肾虚血瘀论治免疫性复发性流产[J]. 长春中医药大学学报, 2020, 36(1): 49-51. CAo T C, LU Q B, XU J Y. Treatment of recurrent immunological abortion from kidney deficiency and blood stasis[J]. Journal of Changchun University of Chinese Medicine, 2020, 36(1): 49-51.
[12]	杨荟璇, 傅萍, 王思慧. 诊治血栓前状态相关复发性流产的中西医研究进展[J]. 成都中医药大学学报, 2020, 43(2): 70-74. https://www.cnki.com.cn/Article/CJFDTOTAL-CDZY202002017.htm YANG Y X, FU P, WANG S H. Research Progress in Diagnosis and Treatment of Prethrombotic Status Related Recurrent Abortion[J]. Journal of Chengdu University of Traditional Chinese Medicine, 2020, 43(2): 70-74. https://www.cnki.com.cn/Article/CJFDTOTAL-CDZY202002017.htm
[13]	吴华夏, 王小莉, 王素琴. 小剂量阿司匹林辅助治疗多囊卵巢综合征不孕效果及对血栓前状态、子宫内膜受容性影响[J]. 中国计划生育学杂志, 2022, 30(4): 746-751. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202204004.htm WU H X, WANG X L, WANG S Q. fficacy of low-dose aspirin in adjuvant treatment of infertility women with polycystic ovary syndrome and its influence on the prethrombotic state and endometrial receptivity[J]. Chinese Journal of Family Planning, 2022, 30(4): 746-751. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202204004.htm
[14]	沙霞, 柳素青, 董叶青, 等. 阿司匹林联合低分子肝素治疗血栓前状态所致复发性流产的效果评价[J]. 浙江临床医学, 2022, 24(4): 557-559. SHA X, LIU S Q, DONG Y Q, et al. Evaluation of the efficacy of aspirin combined with low molecular weight heparin in the treatment of recurrent miscarriage caused by prethrombotic state[J]. Zhejiang Clinical Medical Journal, 2022, 24(4): 557-559.
[15]	SUN D Q, LU S J, GAN X W, et al. Is there a place for Traditional Chinese Medicine(TCM) in the treatment of recurrent pregnancy loss?[J]. J Reprod Immunol, 2022, 152: 103636. DOI: 10.1016/j.jri.2022.103636.
[16]	王思慧, 杨荟璇, 傅萍. 补肾活血中药治疗血栓前状态相关复发性流产[J]. 浙江临床医学, 2022, 24(2): 207-210. WANG S H, YANG H X, FU P. The effect of traditional Chinese medicine of reinforcing kidney and activating blood in the treatment of recurrent spontaneous abortion associated with prethrombotic state[J]. Zhejiang Clinical Medical Journal, 2022, 24(2): 207-210.
[17]	周琦, 宋丽娜, 唐丹艺, 等. 加味当归散合寿胎丸对复发性流产患者抗磷脂抗体异常的影响[J]. 上海中医药杂志, 2020, 54(10): 68-71. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ202010021.htm ZHOU Q, SONG L N, TANG D Y, et al. Effect of Modified Danggui Powder combined with Shoutai Pill on the abnormal anti-phospholipid antibodies in patients of recurrent abortion[J]. Shanghai Journal of Traditional Chinese Medicine, 2020, 54(10): 68-71. https://www.cnki.com.cn/Article/CJFDTOTAL-SHZZ202010021.htm
[18]	马强, 蔺莉, 闫有圣, 等. 经阴道超声联合血清β-hCG、CA-125检测诊断早期流产的临床意义[J]. 中国数字医学, 2020, 15(8): 127-129, 136. https://www.cnki.com.cn/Article/CJFDTOTAL-YISZ202008046.htm MA Q, LIN L, YAN Y S, et al. Clinical Significance of Transvaginal Ultrasound Combined with Serumβ-hCG and CA-125 in the Diagnosis of Early Abortion[J]. China Digital Medicine, 2020, 15(8): 127-129, 136. https://www.cnki.com.cn/Article/CJFDTOTAL-YISZ202008046.htm
[19]	郑玲, 胡艳萍. 低分子肝素联合加味寿胎丸治疗肾虚血瘀型复发性流产的疗效观察[J]. 血栓与止血学, 2022, 28(3): 751-753. https://www.cnki.com.cn/Article/CJFDTOTAL-XSZX202203178.htm ZHENG L, HU Y P. The Rapeutic Efficacy of Low Molecular Weight Heparin Combined with Jiaweishengfetal pill for Recurrent Spontaneous Abortion of Kidney Deficiency and Blood stasis type[J]. Chinese Journal of Thrombosis and Hemostasis, 2022, 28(3): 751-753. https://www.cnki.com.cn/Article/CJFDTOTAL-XSZX202203178.htm
[20]	石玉姣, 谢京红, 李晓俊. 补肾活血中药对血栓前状态复发性流产患者孕前干预的Meta分析[J]. 山东中医杂志, 2022, 41(7): 744-752. https://www.cnki.com.cn/Article/CJFDTOTAL-SDZY202207009.htm SHI Y J, XIE J H, LI X J. Meta-Analysis of Pre-pregnancy Intervention with Chinese Medicnals for Tonifying Kidney and Activating Blood in Patients with Recurrent Spontaneous Abortion of Pre-thrombotic State[J]. Shandong Journal of Traditional Chinese Medicine, 2022, 41(7): 744-752. https://www.cnki.com.cn/Article/CJFDTOTAL-SDZY202207009.htm
[21]	胡婷婷, 蒋启娥. 寿胎丸加味联合黄体酮及低相对分子质量肝素治疗复发性流产的疗效观察[J]. 血栓与止血学, 2021, 27(2): 231-233. https://www.cnki.com.cn/Article/CJFDTOTAL-XSZX202102018.htm HU T T, JIANG Q E. Effect of Shoutai Pill Combined with Progesterone and Low Molecular Weight Heparin in the Treatment of Recurrent Abortion[J]. Chinese Journal of Thrombosis and Hemostasis, 2021, 27(2): 231-233. https://www.cnki.com.cn/Article/CJFDTOTAL-XSZX202102018.htm
[22]	凌爱华, 赵维英. 黄体酮联合加味寿胎丸治疗肾虚型早期先兆流产及对炎症因子影响[J]. 中国计划生育学杂志, 2020, 28(1): 98-101. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202001025.htm LING A H, ZHAO W Y. Effect of progesterone combined with modified shoutai pill for treating pregnant women with early threatened abortion because of kidney deficiency and its influence on inflammatory factors[J]. Chinese Journal of Family Planning, 2020, 28(1): 98-101. https://www.cnki.com.cn/Article/CJFDTOTAL-JHSY202001025.htm